The distribution of IGF2 and IMP3 in osteosarcoma and its relationship with angiogenesis

Journal of Molecular Histology

Volumn 43, Issue 1, 2012, Pages 63-70

  Chen, Peng ^a   Wang, Shao Jin ^a   Wang, Hong Bo ^a   Ren, Peng ^a   Wang, Xi Qian ^a   Liu, Wen Guang ^a   Gu, Wan Li ^a   Li, Dong Qing ^a   Zhang, Ting Guo ^b   Zhou, Cheng Jun ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Angiogenesis; IGF2; IMP3; Osteosarcoma

Indexed keywords

INSULIN LIKE GROWTH FACTOR II MRNA BINDING PROTEIN 3; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER PROGNOSIS; CAPILLARY DENSITY; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MICROVASCULATURE; OSTEOSARCOMA; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; TUMOR VASCULARIZATION;

BONE NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; INSULIN-LIKE GROWTH FACTOR II; INTRACELLULAR SPACE; NEOVASCULARIZATION, PATHOLOGIC; OSTEOSARCOMA; RNA-BINDING PROTEINS;

EID: 84856538959     PISSN: 15672379     EISSN: 15672387     Source Type: Journal    
DOI: 10.1007/s10735-011-9370-2     Document Type: Article

References (47)

1. Alitalo K, Carmeliet P (2002) Molecular mechanisms of lymphangiogenesis in health and disease. Cancer Cell 1(3):219-227 (Pubitemid 41039145)
2. Al-Romaih K, Somers GR, Bayani J (2007) Modulation by decitabine of gene expression and growth of osteosarcoma U2OS cells in vitro and in xenografts: Identification of apoptotic genes as targets for demethylation. Cancer Cell Int 7:14
3. Amit D, Tamir S, Birman T, Gofrit ON, Hochberg A (2011) Development of targeted therapy for bladder cancer mediated by a double promoter plasmid expressing diphtheria toxin under the control of IGF2-P3 and IGF2-P4 regulatory sequences. Int J Clin Exp Med 4(2):91-102
4. Avnet S, Sciacca L, Salerno M, Gancitano G, Cassarino MF, Longhi A, Zakikhani M, Carboni JM, Gottardis M, Giunti A, Pollak M, Vigneri R, Nicola B (2009) Insulin receptor isoform A and insulin-like growth factor II as additional treatment targets in human osteosarcoma. Cancer Res 69(6):2443-2452
5. Baker J, Liu JP, Robertson EJ, Efstratiadis A (1993) Role of insulinlike growth factors in embryonic and postnatal growth. Cell 75:73-82 (Pubitemid 23306022)
6. Baserga R, Hongo A, Rubini M, Prisco M, Valentinis B (1997) The IGF-I receptor in cell growth, transformation and apoptosis. Biochim Biophys Acta 1332(3):F105-F126 (Pubitemid 27272620)
7. Bautista CM, Baylink DJ, Mohan S (1991) Isolation of a novel insulin-like growth factor (IGF) binding protein from human bone: A potential candidate for fixing IGFII in human bone. Biochem Biophys Res Commun 176:756-763
8. Beasley NJ, Prevo R, Banerji S et al (2002) Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer. Cancer Res 62(5):1315-1320 (Pubitemid 34407785)
9. Bjorndahl M, Renhai Cao L, Nissen J, Clasper S, Johnson LA, Xue Y, Zhou Z, Jackson D, Hansen AJ, Cao Y (2005) Insulin-like growth factors 1 and 2 induce lymphangiogenesis in vivo. PNAS 102(43):15593-15598 (Pubitemid 41528101)
10. Cao Y (2005) Opinion: Emerging mechanisms of tumour lymphangiogenesis and lymphatic metastasis. Nat Rev Cancer 5(9): 735-743 (Pubitemid 41486366)
11. Chava S, Mohan V, Shetty PJ, et al. (2011) Immunohistochemical evaluation of p53, FHIT, and IGF2 gene expression in esophageal cancer. Dis Esophagus. 10 June 2011. doi:10.1111/j.1442- 2050.2011.01213.x. [Epub ahead of print]
12. Che W, Lerner-Marmarosh N, Huang Q, Osawa M, Ohta S, Yoshizumi M, Glassman M, Lee JD, Yan C, Berk BC, Abe J (2002) Insulin-like growth factor-1 enhances inflammatory responses in endothelial cells: Role of Gab1 and MEKK3 in TNFalpha- induced c-Jun and NF-kappaB activation and adhesion molecule expression. Circ Res 90(11):1222-1230 (Pubitemid 34786908)
13. Chen ST, Jeng YM, Chang CC, Chang HH, Huang MC, Juan HF, Hsu CH, Lee H, Liao YF, Lee YL, Hsu WM, Lai HS (2011) Insulinlike growth factor II mRNA-binding protein 3 expression predicts unfavorable prognosis in patients with neuroblastoma. Cancer Sci. 14 September 2011. doi:10.1111/j.1349-7006.2011. 02100.x. [Epub ahead of print]
14. Clemmons DR (1997) Insulin-like growth factor binding proteins and their role in controlling IGF actions. Cytokine Growth Factor Rev 8(1):45-62 (Pubitemid 27214688)
15. Cullen KJ, Yee D, Sly WS, Perdue J, Hampton B, Lippman ME, Rosen N (1990) Insulin-like growth factor receptor expression and function in human breast cancer. Cancer Res 50(1):48-53 (Pubitemid 20029992)
16. Dadras SS, Lange-Asschenfeldt B, Velasco P, Nguyen L, Vora A, Muzikansky A, Jahnke K, Hauschild A, Hirakawa S, Mihm MC, Detmar M (2005) Tumor lymphangiogenesis predicts melanoma metastasis to sentinel lymph nodes. Mod Pathol 18(9):1232-1242 (Pubitemid 43079923)
17. Do SI, Kim YW, Park HR, Park YK (2008) Expression of insulin-like growth factor-II mRNA binding protein 3 (IMP3) in osteosarcoma. Oncol Res 17(6):269-272
18. Fidler IJ (2003) The pathogenesis of cancer metastasis: The 'seed and soil' hypothesis revisited. Nat Rev Cancer 3(6):453-458 (Pubitemid 37328849)
19. Fletcher CDM, Unni KK, Mertens F (eds) (2002) World health organization classification of tumours. Pathology and genetics of tumours of soft tissue and bone. IARC Press, Lyon
20. Flossmann-Kast BB, Jehle PM, Hoeflich A, Adler G, Lutz MP (1998) Src stimulates insulin-like growth factor I (IGF-I)-dependent cell proliferation by increasing IGF-I receptor number in human pancreatic carcinoma cells. Cancer Res 58(16):3551-3554 (Pubitemid 28376549)
21. Fokas E, Kamlah F, Hänze J, Engenhart-Cabillic R, Rose F, An HX (2010) EphA2 blockade enhances the anti-endothelial effect of radiation and inhibits irradiated tumor cell-induced migration of endothelial cells. Thorac Cancer 1:153-162
22. Guerra FK, Eijan AM, Puricelli L, Alonso DF, de Kier Joffe EB, Kornblihgtt AR, Charreau EH, Elizalde PV (1996) Varying patterns of expression of insulin-like growth factors I and II and their receptors in murine mammary adenocarcinomas of different metastasizing ability. Int J Cancer 65:812-820 (Pubitemid 26126266)
23. Guo YS, Jin GF Jr, Townsend CM, Zhang T, Sheng HM, Beauchamp RD, Thompson JC (1995) Insulin-like growth factor II expression in carcinoma in colon cell lines: Implications for autocrine actions. J Am Coll Surg 181:145-154
24. Hermanto U, Zong CS, Wang LH (2000) Inhibition of mitogenactivated protein kinase kinase selectively inhibits cell proliferation in human breast cancer cells displaying enhanced insulinlike growth factor I-mediated mitogen-activated protein kinase activation. Cell Growth Differ 11:655-664 (Pubitemid 32042989)
25. Jenkins PJ, Bustin SA (2004) Evidence for a link between IGF-I and cancer. Eur J Endocrinol 151(Suppl 1):S17-S22 (Pubitemid 39276342)
26. Kappel CC, Velez-Yanguas MC, Hirschfeld S, Helman LJ (1994) Human osteosarcoma cell lines are dependent on insulin-like growth factor I for in vitro growth. Cancer Res 54:2803-2807 (Pubitemid 24173778)
27. Kasperk C, Fitzsimmons R, Strong D, Mohan S, Jennings J, Wergedal J, Baylink D (1990) Studies of the mechanism by which androgens enhance mitogenesis and differentiation in bone cells. J Clin Endocrinol Metab 71(5):1322-1329
28. Kasperk CH, Faehling K, Börcsök I, Ziegler R (1996) Effects of androgens on subpopulations of the human osteosarcoma cell line SaOS2. Calcif Tissue Int 58:376-382 (Pubitemid 26136803)
29. Kern PA, Svoboda ME, Eckel RH, Van Wyk JJ (1989) Insulinlike growth factor action and production in adipocytes and endothelial cells from human adipose tissue. Diabetes 38(6):710-717 (Pubitemid 19285723)
30. Khandwala HM, McCutcheon IE, Flyvbjerg A, Friend KE (2000) The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr Rev 21:215-244 (Pubitemid 32275588)
31. Lee OH, Bae SK, Bae MH, Lee YM, Moon EJ, Cha HJ, Kwon YG, Kim KW (2000) Identification of angiogenic properties of insulin-like growth factor II in in vitro angiogenesis models. Br J Cancer 82(2):385-391 (Pubitemid 30045386)
32. Li Y, Meng G, Huang L, Guo QN (2009) Hypomethylation of the P3 promoter is associated with up-regulation of IGF2 expression in human osteosarcoma. Hum Pathol 40(10):1441-1447
33. Long L, Rubin R, Brodt P (1998) Enhanced invasion and liver colonization by lung carcinoma cells overexpressing the type 1 insulin-like growth factor receptor. Exp Cell Res 238(1):116-121 (Pubitemid 28366133)
34. Neuhausen SL, Brummel S, Ding YC, et al. (2011) Genetic variation in IGF2 and HTRA1 and breast cancer risk among BRCA1 and BRCA2 carriers. Cancer Epidemiol Biomarkers Prev. 26 July 2011. [Epub ahead of print]
35. Ogawa O, Eccles MR, Szeto J et al (1993) Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour. Nature 362:749-751 (Pubitemid 23125978)
36. Ohlaaon R, Nystrom A, Pfeifer-Ohlsson S et al (1993) IGF2 is parentally imprinted during human embryogenesis and in the Beckwith-Wiedemann sindrome. Nat Genet 4:94-97 (Pubitemid 23165921)
37. Quinn KA, Treston AM, Unsworth EJ, Miller MJ, Vos M, Grimley C, Battey J, Mulshine JL, Cuttitta F (1996) Insulin-like growth factor expression in human cancer cell lines. J Biol Chem 271:11477-11483 (Pubitemid 26155990)
38. Rainier S, Johnson LA, Dobry CJ, Ping AJ, Grundy PE, Feinberg AP (1993) Relaxation of imprinted genes in human cancer. Nature 362:747-749 (Pubitemid 23125977)
39. Reinmuth N, Fan F, Liu W, Parikh AA, Stoeltzing O, Jung YD, Bucana CD,RadinskyR,GallickGE,EllisLM(2002)Impact of insulin-like growth factor receptor-I function on angiogenesis, growth, and metastasis of colon cancer. Lab Invest 82(10):1377-1389 (Pubitemid 35191541)
40. Ritter MR, Dorrell MI, Edmonds J, Friedlander SF, Friedlander M (2002) Insulin-like growth factor 2 and potential regulators of hemangioma growth and involution identified by large-scale expression analysis. Proc Natl Acad Sci USA 99(11):7455-7460 (Pubitemid 34568712)
41. Rosato R, Gerland K, Jammes H, Bataille-Simoneau N, Segovia B, Mercier L, Groyer A (2001) The IGFBP-3 mRNA and protein levels are IGF-I-dependent and GH-independent in MG-63 human osteosarcoma cells. Mol Cell Endocrinol 175(1-2):15-27 (Pubitemid 32372540)
42. Shigematsu S, Yamauchi K, Nakajima K, Iijima S, Aizawa T, Hashizume K (1999) IGF-1 regulates migration and angiogenesis of human endothelial cells. Endocr J 46(Suppl):S59-S62 (Pubitemid 29254485)
43. Steller MA, Delgado CH, Bartels CJ, Woodworth CD, Zou Z (1996) Overexpression of the insulin-like growth factor I receptor and autocrine stimulation in human cervical cancer cells. Cancer Res 56:1761-1765 (Pubitemid 26118210)
44. Tanno S, Tanno S, Mitsuuchi Y, Altomare DA, Xiao GH, Testa JR (2001) AKT activation up-regulates insulin-like growth factor I receptor expression and promotes invasiveness of human pancreatic cancer cells. Cancer Res 61(2):589-593 (Pubitemid 32128619)
45. Viereck V, Siggelkow H, Pannem R, Braulke T, Scharf JG, Kübler B (2007) Alteration of the insulin-like growth factor axis during in vitro differentiation of the human osteosarcoma cell line HOS 58. J Cell Biochem 102(1):28-40 (Pubitemid 47378909)
46. Xie Y, Skytting B, Nilsson G, Brodin B, Larsson O (1999) Expression of insulin-like growth factor-1 receptor in synovial sarcoma: Association with an aggressive phenotype. Cancer Res 59(15): 3588-3591 (Pubitemid 29381857)
47. Yaginuma Y, Nishiwaki K, Kitamura S, Hayashi H, Sengoku K, Ishikawa M (1997) Relaxation of insulin-like growth factor-II gene imprinting in human gynecologic tumors. Oncology (Basel) 54:502-507 (Pubitemid 27470262)